Novo Nordisk Wins EU Approval for First Oral GLP-1 Weight-Loss Drug Wegovy Written By MD Bureau16 July 2026 6:28 PM ISTBengaluru: Novo Nordisk said on Wednesday the European Commission approved its once-daily Wegovy pill for weight management in adults with obesity or...
Novo Nordisk Nears Europe Launch of Oral Wegovy After EMA Recommendation Written By sheeba farhat23 May 2026 5:02 PM ISTLondon: The European Medicines Agency recommended approval of Novo Nordisk's pill Wegovy, the regulator said on Friday, clearing the way for it to...
Novo Nordisk Beats Q1 Estimates, Raises Outlook on Strong Wegovy Demand Written By sheeba farhat6 May 2026 4:53 PM ISTCopenhagen: Novo Nordisk, the maker of weight-loss drug Wegovy, on Wednesday reported first-quarter revenue and adjusted operating profit above...
Eli Lilly's Foundayo Sees Slow Start in U.S., Trails Novo Nordisk's Wegovy in Early Prescription Race Written By sheeba farhat2 May 2026 10:00 AM ISTBengaluru: Eli Lilly's newly launched oral weight-loss drug, Foundayo, was prescribed 5,612 times in the U.S. in the third week after its launch,...
USFDA Flags Liver Safety Concerns, Asks Eli Lilly for Additional Data on Obesity Pill Foundayo Written By sheeba farhat15 April 2026 7:35 PM ISTNew Delhi: The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury linked to its newly approved ​obesity pill,...
USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk Written By sheeba farhat3 April 2026 2:49 PM ISTWashington: The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up the next battle with Novo Nordisk for the millions of...
USFDA Flags Novo Nordisk's Wegovy Advertisement as False, Seeks Immediate Action Written By sheeba farhat11 Feb 2026 8:19 PM ISTUSFDA said the television spot misleadingly suggests that Wegovy in ‌its pill form offers an advancement or improvement over other weight-loss drugs...
Novo Nordisk Projects Oral Weight-Loss Pills to Take One-Third of GLP-1 Market by 2030 Written By sheeba farhat13 Jan 2026 5:23 PM ISTNovo launched a daily oral ​version of Wegovy in the U.S. earlier this month with a starting cash price ​of USD 149 per month.
